Paradigm Diagnostics grabs $7 mln Series B


Paradigm Diagnostics, a molecular information company, has closed $7 million in Series B financing. The investors included New Sciences Ventures and Mesa Verde Venture Partners.

Source: Press Release

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!